Telomerase activity and telomere length in human benign prostatic hyperplasia stem-like cells and their progeny implies the existence of distinct basal and luminal cell lineages

European Urology

Volumn 69, Issue 4, 2016, Pages 551-554

  Rane, Jayant K ^a,e   Greener, Sarah ^a,f   Frame, Fiona M ^a   Mann, Vincent M ^b,c   Simms, Matthew S ^b,c   Collins, Anne T ^a   Berney, Daniel M ^d   Maitland, Norman J ^a,b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c CASTLE HILL HOSPITAL   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Benign prostatic hyperplasia; Stem cells; Telomerase

Indexed keywords

TELOMERASE; BIOLOGICAL MARKER; RNA; TELOMERASE RNA; TERT PROTEIN, HUMAN;

ARTICLE; BASAL CELL; CELL DIVISION; CELL LINEAGE; CELL PROLIFERATION; CELL SUBPOPULATION; DNA SEQUENCE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SOMATIC CELL; STROMA CELL; TELOMERE; TELOMERE SHORTENING; TRANSURETHRAL RESECTION; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE; PROSTATE; PROSTATIC HYPERPLASIA; STEM CELL; TELOMERE HOMEOSTASIS;

BIOMARKERS; CELL LINEAGE; CELL PROLIFERATION; HUMANS; MALE; PHENOTYPE; PROSTATE; PROSTATIC HYPERPLASIA; RNA; STEM CELLS; TELOMERASE; TELOMERE HOMEOSTASIS; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 84959570586     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.09.039     Document Type: Article

References (12)

1. T. Vos, A.D. Flaxman, M. Naghavi, and et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease study 2010 Lancet 380 2012 2163 2196
2. A.K. Meeker Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology Urol Oncol 24 2006 122 130
3. N. Kyprianou, H. Tu, and S.C. Jacobs Apoptotic versus proliferative activities in human benign prostatic hyperplasia Hum Pathol 27 1996 668 675
4. G.D. Richardson, C.N. Robson, S.H. Lang, D.E. Neal, N.J. Maitland, and A.T. Collins CD133, a novel marker for human prostatic epithelial stem cells J Cell Sci 117 2004 3539 3545
5. D. Pellacani, D. Kestoras, A.P. Droop, and et al. DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation Cell Death Differ 21 2014 761 773
6. J.K. Rane, M.S. Simms, N.J. Maitland, Re: Yves Allorya, Willemien Beukers, Ana Sagrera, and et al. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. Eur Urol 2014;65:360-6: telomerase expression and stem cells: urologic epithelial perspective Eur Urol 65 2014 e85 e86
7. M. Ousset, A. Van Keymeulen, G. Bouvencourt, and et al. Multipotent and unipotent progenitors contribute to prostate postnatal development Nat Cell Biol 14 2012 1131 1138
8. E.S. Polson, J.L. Lewis, H. Celik, and et al. Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells Nat Commun 4 2013 1623
9. D.G. Bostwick The pathology of benign prostatic hyperplasia P. Kirby, J.D. McConnell, J.M. Fitzpatrick, Textbook of Benign Prostatic Hyperplasia. 2002 Isis Medical Media London, UK
10. H. Bonkhoff, U. Stein, and K. Remberger The proliferative function of basal cells in the normal and hyperplastic human prostate Prostate 24 1994 114 118
11. J.E. McNeal, O. Haillot, and C. Yemoto Cell proliferation in dysplasia of the prostate: analysis by PCNA immunostaining Prostate 27 1995 258 268
12. X. Wang, M. Kruithof-de Julio, K.D. Economides, and et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer Nature 461 2009 495 500